Compared to screen film mammography, researchers found digital mammography could more clearly depict calcifications, see through denser breast tissue and allowed the reader to adjust the actual image, according to a new study published Dec. 11 in Radiology.

Researchers from the Mayo Clinic in Rochester, Minnesota found that 98 percent of digital breast tomosynthesis-detected masses sent to ultrasound directly were adequately evaluated without the use of diagnostic mammography, according to research published Nov. 29 in the British Journal of Radiology.

A new technique called three-compartment breast (3CB) imaging, which determines the biological tissue composition of a tumor by using mammography, may help reduce unnecessary breast biopsies, costs and patient anxiety, according to a new study published online Dec. 11 in Radiology.

New research presented at RSNA 2018 in Chicago suggested women 75 years and older should continue to get annual screening mammograms due to the high incidence of breast cancer found in this population.

A husband-and-wife research team at the University of Virginia (UVA) Cancer Center in Charlottesville, was awarded a five-year, $1.8 million grant from the National Institutes of Health (NIH) to improve their advanced radiation therapy technique for early-stage breast cancer patients, according to a UVA press release published Nov. 15.

News coverage of mammography screening recommendations often conveys a controversial and/or conflicting tone, which researchers say may negatively influence a woman's decision regarding breast cancer screening and trust in cancer prevention recommendations, according to research published online Nov. 5 in Women’s Health Issues.

Women with early-stage breast cancer who receive large doses of radiation once a week for five weeks will experience the same long-term side effects as women who undergo conventional radiation therapy, according to a ten-year study presented Oct. 21 at the 2018 American Society for Radiation Oncology (ASTRO) annual meeting in San Antonio, Texas.

"Despite the help offered by this classification system, the BI-RADS 3 category includes probably benign lesions whose management has been widely debated in the literature," wrote Chiara Adriana Pistolese, from the department of diagnostic imaging at Tor Vergata University Rome in Italy, and colleagues.